Davis Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.53M Sell
17,781
-128
-0.7% -$11.3K 0.92% 27
2026
Q2
$1.4M Buy
17,909
+2,794
+18% +$225K 0.83% 32
2026
Q1
$1.31M Buy
15,115
+641
+4% +$61.4K 0.89% 37
2025
Q4
$1.39M Buy
14,474
+1,273
+10% +$124K 0.96% 29
2025
Q3
$1.26M Buy
+13,201
New +$1.21M 0.87% 36
2025
Q1
$640K Buy
7,117
+1,223
+21% +$109K 0.51% 57
2024
Q4
$471K Buy
5,894
+1,589
+37% +$138K 0.38% 63
2024
Q3
$388K Sell
4,305
-124
-3% -$10.4K 0.31% 63
2024
Q2
$342K Sell
4,429
-358
-7% -$29.3K 0.3% 65
2024
Q1
$417K Sell
4,787
-612
-11% -$52.2K 0.37% 60
2023
Q4
$445K Buy
+5,399
New +$411K 0.43% 56
2020
Q2
$896K Sell
9,772
-127
-1% -$12.2K 1.66% 17
2020
Q1
$893K Buy
+9,899
New +$1.05M 1.9% 13

Other funds holding MDT

Davis Capital Management's MDT Position: Q3 2026 in Review

Davis Capital Management reduced its Medtronic (MDT) stake by 0.71% in Q3 2026, selling an estimated $11.3K and leaving 17,781 shares worth $1.53M. The position accounts for 0.92% of the portfolio, ranked #27.

Davis Capital Management first reported a position in MDT in Q1 2020 and has held it in 13 quarters since. 752 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Davis Capital Management held 17,781 shares of Medtronic worth $1.53M as of Q3 2026.
  • Davis Capital Management sold 128 Medtronic shares in Q3 2026, an estimated $11.3K.
  • Medtronic made up 0.92% of Davis Capital Management's portfolio in Q3 2026, its #27 holding.
  • Davis Capital Management first reported a position in Medtronic in Q1 2020 and has held it in 13 quarters since.
  • 752 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.